Karen Bernstein Insider Profile
4 Followers
Karen Bernstein, Director at Ovid Therapeutics, holds 20.00K shares in Ovid Therapeutics (Ticker: OVID), holds ― shares in Achaogen (Ticker: AKAOQ), holds 0.00 shares in Vitae Pharma (Ticker: VTAE). Most recently, Karen Bernstein Bought ― shares of Ovid Therapeutics on Feb 28, 2019 for an estimated value of $20.20K.
Karen Bernstein's Trading History
| OVIDOvid Therapeutics | Feb 28, 2019 | Director | Informative Buy | 20.20K | $48.00K | |
| CDAKQCodiak BioSciences | ― | ― | ― | $96.25 | ||
| VTAEVitae Pharma | ― | ― | ― | $0.00 | ||
| AKAOQAchaogen | ― | ― | ― | ― |
You May Also Like
Karen Bernstein insider profile FAQ
What is the percentage of profitable transactions made by Karen Bernstein?
The percentage of profitable transactions made by Karen Bernstein is 50%.
What is the average return per transaction made by Karen Bernstein?
The average return per transaction made by Karen Bernstein is -5.70%.
What stocks does Karen Bernstein hold?
Karen Bernstein holds: OVID, AKAOQ, VTAE, CDAKQ stocks.
What was Karen Bernstein’s latest transaction?
Karen Bernstein’s latest transaction was an Informative Buy of $20.20K.
What was Karen Bernstein's most profitable transaction?
Karen Bernstein’s most profitable transaction was an Informative Buy of OVID stock on February 28, 2019. The return on the trade was 59.20%.
What is Karen Bernstein's role in Ovid Therapeutics?
Karen Bernstein's role in Ovid Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
